Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 trial of an antitumor agent (Japan, jRCT2080225087)
jRCT2080225087Phase 2Completed
- Start
- Feb 2020
- Countries
- 1
01
Overview
Phase 2 trial in cancer. Started Feb 2020; status: completed.
02
Conditions
cancer
Beyond the preview
Go deeper on jRCT2080225087.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080225087.